InformDS Technologies Pvt. Ltd., the company behind Doxper, has raised US$4 million in the first close of its Series A round led by healthcare focused fund Alkemi. Also participating in this round are Rainforest Venture Network, existing investor growX Ventures and some marquee angel investors.
Doxper, founded by 3 IIT alumni, is an ML/AI powered data capture solution that allows doctors to instantly digitise their case sheets using a digital pen and encoded paper. The solution can be fully integrated with any existing EMR systems. In more than 100 countries with a poor doctor-patient ratio, prescriptions and case histories are still “analog”, unlike data output from imaging, pathology, genomics etc which have long gone digital. Handwritten notes on paper pose the most serious impediment to the promise of ‘Digital Health’.
Doxper today is serving nearly 1600 independent clinics and 20 of the country’s top corporate hospitals, including 3 chains. The company is processing close to 500K case sheets every month and has so far, through its platform, digitized case sheets of over 3.25 million unique patients, with a total of nearly 5 million records.
Shailesh Prithani, Co-Founder & CEO, added, “Doxper today is the country’s fastest growing solution of choice for digitisation of healthcare. With increasing competition, patient empowerment and several converging standards and regulations such as the Personal Data Protection Bill, the National Digital Health Blueprint and stricter data compliance in the amendment to the Clinical Establishments Act, digitising patient records has evolved very rapidly from a ‘good to have’ to a ‘must have’. We are thrilled to have Alkemi lead our Series A round, along with several top-notch investors. We are grateful for their belief in not only what has been achieved, but the direction India must take and Doxper’s central role in Indian healthcare’s digital story.
“The biggest obstacle to data digitization is workflow change expected on behalf of stakeholders. Doxper solution is simple and unique making compliance easier. We are very excited to partner and support Doxper to fuel their growth in this sector.” said an Alkemi spokesperson.
The company plans to use the funds to double down on its growth in India expanding geographically across the country. Further investments in technology and R&D are planned to improve the accuracy of the ML/AI powered handwriting recognition engine and to develop products in business and clinical analytics.
Coverage: